Work

A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis

Year: 2007

Type: article

Source: Journal of Neurology

DOI: 10.1007/s00415-006-0356-z

Authors: Derek Soon, Daniel R. Altmann, Kryshani T.M. Fernando, Garin Giovannoni, Frederick Barkhof, Chris H. Polman, Paul O’Connor, Bruce Gray, Michael Panzara, David H. Miller

Institutions: National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, London School of Hygiene & Tropical Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, St. Michael's Hospital, St Michael’s Hospital, St Michael's Hospital, Biogen (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Biogen, Multiple Sclerosis Society, IC Design Education Center

OpenAlex ID: W2012102744

FWCI: 1.324

Cites: 38

Cited by: 33

Related to: 10